FDA Approves Fetroja (cefiderocol) for the Treatment of Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia

OSAKA, Japan& FLORHAM PARK, N.J.--(BUSINESS WIRE) September 28, 2020 --Shionogi& Co., Ltd. (hereafter“Shionogi”) today announces that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news